SEATTLE - Life expectancy in Russia between 1994 and 2016 increased by more than 7 years, while rates of death among children under age 5 decreased nearly 60%, according to the most extensive health study on the nation ever conducted.
In addition, age-adjusted rates of premature death from smoking, one of the world's most substantial health risks, dropped by nearly 34% over the same time period. Russia also saw progress in reducing premature death (as measured in years of life lost (YLLs) from stomach cancer, drowning, and chronic obstructive pulmonary disease.
"These are significant accomplishments," said Dr. Mohsen Naghavi, a professor of health metrics sciences at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. "Russia's public health officials deserve recognition for their efforts lowering the country's burden of disease."
However, the study, published today in the international medical journal The Lancet, concludes the nation continues to face considerable health challenges.
Despite improvement from the mid-1990s, a nearly 11-year gap in life expectancy remained between Russian men and women in 2016. Moreover, Russia exceeds all other countries for age-adjusted premature death rates attributed to alcohol use disorders and has the second-highest premature death rate from drug use globally.
"Like many other nations, more than half of all deaths in Russia can be attributed to behavioral risk factors, most prominently alcohol and substance abuse," said Dr. Christopher Murray, an author on the study and director IHME.
The study, "Burden of disease in Russia, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016," was published today in the international medical journal The Lancet. It is part of the Global Burden of Disease (GBD) study, a comprehensive effort to quantify health internationally, covering 333 diseases and injuries and 84 risk factors.
There are 3,676 collaborators on the GBD, including 20 in Russia. It is the world's largest scientific collaboration and is widely viewed as the most authoritative health study. Earlier this year, the leadership of IHME and the World Health Organization signed a memorandum of understanding to work together on the GBD, "thereby strengthening the study for national and local decision-making by health officials and practitioners."
The Russia study was led by Dr. Vladimir Starodubov, director of the Federal Research Institute for Health Organization and Informatics (FRIHOI) of the Ministry of Health, and was written in partnership with Russian experts, as well as representatives from the WHO European Office and IHME. A majority of the study authors are Russian.
It estimates life expectancy, prevalence, incidence, deaths, and several other summary health metrics.
Among the findings:
- In 2016, life expectancy at birth for males in Russia was 65.4 years, whereas for females it was 76.2 years; for males, this marks an improvement from 57.4 in 1994, and for females, an improvement from 70.8 the same year.
- With age-adjusted premature rates of 680 YLLs per 100,000 people, premature mortality from alcohol use disorders in Russia in 2016 is the highest in the world, followed next by Mongolia at 647 YLLs per 100,000 people.
- Russia's age-adjusted premature death rates for drug use disorders (447 YLLs per 100,000 people) is second highest in the world.
- Child mortality rates decreased between 2000 and 2016 by 58%.
- Russian men have a disproportionately high burden of disease relative to women.
- Age-adjusted rates of premature mortality in 2016 were higher for men than for women across all 20 leading causes of YLLs.
- Age-adjusted premature mortality rates for cirrhosis and other chronic liver diseases due to alcohol use among both men and women increased by 43% between 2000 and 2016.
- Age-adjusted rates of premature death from lung cancer were more than seven times higher for men than for women, and suicide rates were almost six times higher.
- For men aged 15-49 years, alcohol use contributed to one in three deaths (34%) in 2016.
According to Starodubov, "Significant improvements in the health indicators of the population of the Russian Federation have been achieved and it is a credit to state alcohol policy, improving medical care, and increasing attention to a healthy lifestyle."
Researchers found more than half of all deaths in Russia are attributable to behavioral risk factors, such as smoking, alcohol use, dietary risks, low physical activity, drug use, and unsafe sex. However, high blood pressure, a metabolic risk factor, was the leading risk for death in Russia, accounting for nearly one in three deaths in 2016.
"Despite the challenges Russia is facing, the nation's population health leaders have made progress in addressing some key problems," Murray said. "The insights from this comprehensive study should be enlightening to policymakers and others responsible for planning and delivering health services for the nation's 144 million people."
Top 10 causes of premature mortality in 2016:
- Ischemic heart disease
- Road injuries
- Lower respiratory infections
- Lung cancer
- Alcohol use disorders
- Interpersonal violence
Top 10 risk factors contributing to premature mortality in 2016 (ranking based on all ages rates of YLLs per 100,000 people):
- High systolic blood pressure
- Alcohol use
- High total cholesterol
- High body-mass index
- Diet low in whole grains
- High fasting plasma glucose
- Diet low in fruits
- Diet low in nuts and seeds
- Ambient particulate matter pollution
IHME: Kelly Bienhoff, +1-206-897-2884 (office); +1-913-302-3817 (mobile); email@example.com
IHME: Dean Owen, +1-206-897-2858 (office); +1-206-434-5630 (mobile); firstname.lastname@example.org
The Lancet: Emily Head, +44 (0) 207 424 4249 (office); +44 (0) 7920 530 997 (mobile); email@example.com
About the Institute for Health Metrics and Evaluation
The Institute for Health Metrics and Evaluation (IHME) is a non-governmental organization focusing on global health research at the University of Washington. IHME provides rigorous and comparable measurement of the world's most important health problems and evaluates the strategies used to address them. IHME makes this information widely available so that policymakers have the evidence they need to make informed decisions about how to allocate resources to improve population health.
About the Global Burden of Disease study
The Global Burden of Disease (GBD) study is the largest and most comprehensive effort to quantify health loss across places and over time. It draws on the work of more than 3,676 collaborators from 143 countries and two territories. The Institute for Health Metrics and Evaluation coordinates the study. The GBD 2016 study was published in October 2017 and covers 333 diseases and injuries, and 84 risk factors.